Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Cash from Financing Activities (2022 - 2025)

Historic Cash from Financing Activities for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $1.9 million.

  • Gossamer Bio's Cash from Financing Activities rose 56619.22% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 11716.35%. This contributed to the annual value of -$11.5 million for FY2024, which is 10604.14% down from last year.
  • As of Q3 2025, Gossamer Bio's Cash from Financing Activities stood at $1.9 million, which was up 56619.22% from $94000.0 recorded in Q2 2025.
  • Over the past 5 years, Gossamer Bio's Cash from Financing Activities peaked at $198.5 million during Q3 2023, and registered a low of -$9.2 million during Q2 2024.
  • Its 4-year average for Cash from Financing Activities is $21.3 million, with a median of $57500.0 in 2022.
  • As far as peak fluctuations go, Gossamer Bio's Cash from Financing Activities crashed by 1392857.14% in 2023, and later soared by 56619.22% in 2025.
  • Quarter analysis of 4 years shows Gossamer Bio's Cash from Financing Activities stood at -$2.9 million in 2022, then fell by 1.04% to -$2.9 million in 2023, then surged by 109.68% to $281000.0 in 2024, then surged by 566.19% to $1.9 million in 2025.
  • Its Cash from Financing Activities stands at $1.9 million for Q3 2025, versus $94000.0 for Q2 2025 and $504000.0 for Q1 2025.